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Abstract 
 
Objective: Older spousal caregivers of dementia patients have been found to show a 
relatively poor antibody response to medical vaccination.  The present case control 
study compared the antibody responses to vaccination of younger parental caregivers 
of children with developmental disabilities and parents of typically developing 
children.  Methods: At baseline assessment, 32 parents of children with 
developmental disabilities and 29 parents of typically developing children completed 
standard measures of perceived stress and child problem behaviours.  They also 
provided a blood sample and were then vaccinated with the thymus-dependent 
trivalent influenza vaccine.  Further blood samples were taken at 1- and 6-month 
follow-ups.  Results: Relative to parents of typically developing children (mean titre 
= 458, SD = 155.7 at 1-month and mean titre = 265, SD = 483.0 at 6-month follow-
up) caregivers (mean titre = 219, SD = 528.4 at 1-month and 86, SD = 55.0 at 6-
month) mounted a poorer antibody response than controls to the B/Malaysia strain of 
the vaccine.  It was those caregivers reporting more child problem behaviours that 
tended to show the weakest antibody response.  Conclusion: The negative impact of 
caregiving on antibody response to vaccination would not appear to be restricted to 
older spousal caregivers, but is also evident in younger parents caring for children 
with developmental disabilities.  The behavioural characteristics of the care recipients 
may be a determinant of whether or not antibody response to vaccination is 
compromised.  
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INTRODUCTION                                                                                                         
 
       In humans, the effects of chronic stress on immunity have been studied by 
comparing caregivers who provide care to sick or disabled relatives with broadly 
matched controls (1-6) and the antibody response to vaccination is regarded as a 
useful model for the studying the effects of stress in this context (7-9).  Older spousal 
caregivers of dementia patients have been found to show a relatively poor antibody 
response to both influenza and pneumococcal vaccinations (5, 10, 11), implying a 
reduced capacity to fight viral and bacterial infections.  However, younger caregivers 
have rarely been studied in this context.   
    Only two studies have examined these younger caregiver cohorts, with mixed 
results (12, 13).  Caregivers of multiple sclerosis patients did not differ from controls 
in antibody response to the influenza vaccination (13).  This raises the issue of 
whether the poor antibody response observed in older caregivers is a function of an 
interaction between chronic stress exposure and immunosenescence, (14, 15) and will 
be less likely to occur in younger caregivers.  We have postulated that rather than 
immunosenescence, it is possible that it is the intensity of the chronic stress 
experienced that determines the influence of caregiving on immunity.  The precise 
caregiving experience may vary between those caring for patients with multiple 
sclerosis and dementia.  Indeed, older spousal caregivers of dementia patients have 
been found to report greater distress than younger multiple sclerosis caregivers (13).  
A model that would help us to test these hypotheses is parents’ caregiving for children 
with developmental disabilities.  Dealing with severe cognitive difficulties and 
behaviours that are problematic and distressing are the main challenges for both 
parents of children with developmental disabilities (16, 17) and caregivers of 
dementia patients (18, 19).  In addition, caring for someone with a mental health 
problem has been found to be more stressful than caring for someone with a physical 
health problem (e.g., cancer) (19), a likely consequence of the repetitive challenges 
faced by such caregivers on a daily basis.  In our recent study we demonstrated that 
parents of children with developmental disabilities mounted a poorer response to a 
pneumococcal vaccination (12)  
     The pneumococcal vaccination is a thymus-independent bacterial vaccine; the 
formation of antigen-specific antibodies does not require and cannot receive the help 
of T-cells.  Influenza and other viral vaccines are thymus-dependent and require the 
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help of T-cells for antibody production.  It has yet to be demonstrated that the 
antibody response to a thymus-dependent vaccination is compromised in younger 
caregivers.  Consequently, we compared the antibody responses to the trivalent 
thymus-dependent influenza vaccine in relatively young parents caring for children 
with developmental disabilities and parents caring for typically developing children.  
It was hypothesised that parents of children with developmental disabilities would 
report substantially more distress and mount a poorer antibody response.   
 
METHOD 
 
       Participants  
      A more detailed description of some of the methodology is available elsewhere, as 
we have previously reported differences between these caregivers and controls in 
antibody response to pneumococcal vaccination (12).  Thirty-two parents caring for 
children with developmental disabilities and 29 parents of typically developing 
children participated.  All parents were volunteers recruited through media campaigns 
and those contacting were informed that is was a study examining antibody response 
to vaccination in parents of children with developmental disabilities and parents of 
typically developing children.  Inclusion criteria for these parents were: caring for at 
least one child with Autism, Downs, Cornelia de Lange, or Smith-Magenis 
syndromes; children had to be aged between 3 and 19 years and cared for at home 
during the school term.  The majority of parents reported caring for a child with 
Autism (66%); the remainder were caring for a child with Downs (22%) or with other 
syndromes (12%).  Controls were parents of typically developing children.  No parent 
had received the influenza vaccine previously or had a history of negative reactions to 
blood sampling (e.g., fainting).  Attempts were made to match the groups on age, sex, 
socioeconomic position, ethnicity, and marital status.  The study was approved by the 
appropriate Medical Research Ethics committee and all participants provided 
informed consent.  
 
Study design and procedure 
      Participants were tested between December 2006 and December 2007.  At 
baseline, parents completed questionnaires and then provided a blood sample to 
determine baseline antibody status.  After medical screening, they were vaccinated 
 6
with the 2006/07 season Inflexal influenza vaccine (Sanofi Pasteur, MSD) containing 
A/New Caledonia/20/99 (H1N1), A/Wisconsin/67/2005 (H3N2), 
B/Malaysia/2506/2004-like virus strains.  Follow-up blood samples were collected 1-
month (N = 60) and 6-months later (N = 57).  One caregiving parent relocated and 
was therefore unable to attend their next appointments; the remaining parents who 
were not available for the final follow-up cited issues of family commitments as the 
main reason for non-attendance.  
 
Questionnaires 
      Psychological stress over the previous month was measured using the 14-item 
Perceived Stress Scale (20).  The 25-item Strengths and Difficulties Questionnaire 
(21) was used to assess child problem behaviours.  Parents are asked to rate whether a 
behaviour is somewhat true, 0, true, 1, or certainly true, 2, of their child, with higher 
scores indicating more problem behaviour.  Examples include ‘often fights with other 
children and bullies them’ and some items are reversed scored (e.g. generally 
obedient, usually does what adults request).  The scale has been shown to be reliable 
(Cronbach’s α = .76) and effective at identifying behavioural problems in children 
(22).  Internal consistency for the scale in this study was .88.  As in our previous 
research (23-25), typical health behaviours were assessed at baseline, using a 
questionnaire adapted from the Whitehall II study (26).      
 
Blood sampling and antibody analysis 
     Anti-influenza antibody titres were measured in venous blood by Glaxo 
SmithKline Beecham (Dresden, Germany), using a haemagglutination inhibition test 
(WHO). The antibody results are reported as titres; a titre represents the reciprocal of 
the highest dilution having a positive response in the haemagglutination inhibition 
assay.  
 
Statistical analyses 
      Given a degree of skew in these data, all analyses were performed on log10 
antibody levels.  Repeated measures ANCOVA was used to test whether the groups 
differed at follow-up; since interest lay in the antibody response, baseline log10 
antibody titre was entered as a covariate as in our previous studies (24, 27).  Partial 
eta-squared (η2) is reported as a measure of effect size.  Further ANCOVAs were 
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undertaken to adjust for possible confounders and test for possible mediators. 
Hierarchical linear regression analyses were used within the caregiving group to 
determine whether perceived stress, child problem behaviour, or age was associated 
with antibody response.  
 
RESULTS  
Demographics and psychosocial status  
      The summary characteristics of the caregivers and controls are presented 
elsewhere (12).  Caregivers and controls were well-matched on most variables and did 
not differ on health behaviours.  However, parents of children with developmental 
disabilities were found to differ on the following age, (mean = 42.8, SD = 5.95, and 
mean = 39.9, SD = 4.35, for the caregivers and controls respectively), F (1,57) = 4.44, 
p = .04; child’s age, (mean 11.5, SD = 3.41, and mean = 8.8, SD = 4.22, respectively), 
F (1,57) = 7.18, p = .01, and hours spent caregiving each day, (mean = 10.6, SD = 
8.19, and mean = 3.5 , SD = 3.53, respectively), F (1,56) = 17.89, p <.001.  Parents of 
children with developmental disabilities also reported higher perceived stress (mean = 
30.3, SD = 8.40, and mean = 22.2, SD = 7.48), for the caregivers and controls 
respectively), F (1,57) = 15.52, p <.001, and more child problem behaviours, (mean = 
23.0, SD = 5.97, and mean = 9.9, SD= 4.89, respectively), F (1,57) = 84.64, p <.001.    
 
    
Caregiving and Antibody response 
      The mean (SE) antibody titre for each of the influenza strains at each time point 
for caregivers and controls is displayed in Figure 1.  ANCOVA revealed highly 
significant variations in log10 antibody titre over time for each strain: A/New 
Caledonia, F(2, 53) = 138.35, p < .001, η2 = .719; A/Wisconsin, F(2, 53) = 72.19, p < 
.001, η2 = .572; B/Malaysia, F(2, 53) =  226.74, p < .001, η2 = .808.  After adjusting 
for log10 baseline antibody levels, ANCOVA revealed a main effect of group on log10 
antibody response for the B/Malaysia strain, F(1,53) = 4.22, p = .04, η2 = .074, with 
caregivers mounting a poorer response.  There were no significant group effects for 
A/New Caledonia or A/Wisconsin.  The group effect for the B/Malaysia withstood 
adjustment for age of parents and children and time spent caregiving, F(1,49) = 4.92, 
p = .03, η2 = .091.  However, in models in which perceived stress and child problem 
behaviour were also entered, the group effect was no longer significant, F(1,48) = 
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3.67, p = .06, η2 = .071, and F(1,47) = 3.32, p = .07, η2 = .066,  respectively.  This 
suggests that at least some of the group variation in antibody response is determined 
by variations in perceived stress and child problem behaviour.  In terms of non-
responsiveness, 19% of caregivers compared to only 6% of controls failed to mount a 
four-fold increase in B/Malaysia tires at 1-month.  
 
[Insert Figure 1 about here] 
 
Within caregivers  
     In hierarchical linear regression analyses, again adjusting for baseline titre, no 
significant associations emerged between perceived stress and child problem 
behaviours and antibody response to the B/Malaysia strain.  However, there were 
indications of a negative relationship between child problem behaviour and 6-month 
antibody response, β = -.32, t = -1.67, p = .10, ΔR2 = .10.  To illustrate this effect we 
divided caregivers into those reporting high and low behaviour problems using a 
median split (see Figure 2).  Finally, we examined the association between age of 
caregivers and their antibody response to the B/Malaysia strain.  There was a 
tendency for older caregivers to mount a poorer antibody response at 1-month, β = -
.33, t = -1.87, p = .07, ΔR2 = .11.  
 
[Insert Figure 2 about here] 
 
DISCUSSION  
 
      Compared to parents of typically developing children, young parents caring for 
children with developmental disabilities mounted a poor antibody response to the 
B/Malaysia strain of the influenza vaccine.  The present findings are consistent with 
those of studies of older spousal caregivers (5, 11).  They also extend our results with 
the thymus-independent pneumococcal vaccine (12), implying that these relatively 
young parental caregivers may have a reduced ability to fight both bacterial and viral 
infections.  The present study reinforces the hypothesis that an ageing immune system 
is not a pre-requisite for a poor response to medical vaccination in caregivers.  
Nevertheless, older caregivers tended to have a poorer antibody response to 
B/Malaysia at 1-month, suggesting that we cannot dismiss the hypothesis that chronic 
 9
stress and immunosenescence may have synergistic effects (14).  Whether or not 
caregivers exhibit a poor antibody response to vaccination would seem to depend on 
the characteristics of the caregiving experience rather than caregiving per se.  This 
could explain the difference between our findings and an earlier report that younger 
spousal caregivers of multiple sclerosis patients did not differ from controls in their 
antibody response to influenza vaccination (13).  A comparison of perceived stress 
scores between studies revealed that the present caregivers experienced much more 
stress than those caring for spouses with multiple sclerosis (12).   
      It would also appear that some influenza strains are more susceptible than others 
to psychosocial influence.  Such specificity has been reported in previous studies of 
influenza vaccination (5, 25, 28).  It is difficult at this stage to determine why 
particular vaccine strains are sensitive to certain types of psychosocial influence.  One 
explanation for such specificity is that less immunogenic antigens are more 
susceptible to exogenous influence (9).  Alternatively, strain novelty is another 
characteristic of antigens that may underlie such specificity.  For example, the 
negative effects of psychological stress on the antibody response to the trivalent 
influenza vaccination were observed for viral strains recently introduced to the 
vaccine (5, 25, 29).  It is worth noting that the A/New Caledonia strain has been a 
component of the northern hemisphere influenza vaccine since 2004, and thus current 
rates of naturalistic exposure are likely to be high and novelty is likely to be lower in 
the present study.  In contrast, examination of the B strains comprising the influenza 
vaccination in previous years (B/Shanghai) indicates that the B/Malaysia is a novel 
component in the current vaccine.  Further, although parents reported not having any 
previous influenza vaccines, prior exposure cannot be ruled out and epidemiological 
evidence shows that the majority of circulating viruses in Europe in the year prior to 
the study were closely related to A/Caledonia (H1N1) and antigenically related to 
A/Wisconsin (H3N2) (30), thus increasing the antigenic novelty of the B/Malaysia 
strain.   
     Adjustment for perceived stress and child problem behaviour attenuated the group 
differences in antibody response to the B/Malaysia strain and caregivers reporting 
more child problem behaviour tended to mount a poorer antibody response.  This 
finding is consistent with our results for pneumococcal vaccination (12) and broadly 
in line with the results of research with caregivers of patients with mental health 
difficulties using other health indicators (18, 19, 31, 32).  Further, interventions for 
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managing and preventing care recipients’ behaviour problems were found to enhance 
caregivers’ immunity immediately after intervention and 6-months later (33).  Taken 
together, these data indicate that problem behaviours may be a key determinant of 
caregivers’ health and that interventions targeting such behaviours may bring health 
benefits.    
       The present study has a number of limitations.  Our sample size might be 
regarded as small, but it is the same order of magnitude as other case-control 
vaccination studies (10, 13).  There is also the possibility of confounding as a result of 
unmeasured variables or imperfect matching among participants.  However, our main 
findings survived statistical adjustment for a number of potential confounders.  
      In summary, the negative impact of caregiving on antibody response to 
vaccination is not restricted to older spousal caregivers, but is also evident in younger 
parents caring for children with developmental disabilities.  Nor is it restricted to 
thymus-independent antigens.  Finally, it would appear that the behavioural 
characteristics of care recipients may influence whether or not antibody response to 
vaccination is compromised in their caregivers. 
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Figure 1. Mean (SE) antibody titre for the three vaccine strains for caregivers and 
controls at baseline, 1-month and 6-months.  
 
Figure 2.  Mean (SE) B/Malaysia log10 antibody titre at 6-month follow-up, adjusted 
for baseline antibody titre, for caregivers reporting high and low child problem 
behaviour.   
